Your browser doesn't support javascript.
loading
Prolonged SARS-CoV-2 Illness in a Patient Receiving Ocrelizumab for Multiple Sclerosis.
Gibson, Elena G; Pender, Melissa; Angerbauer, Michael; Cook, Craig; Jones, Barbara; Spivak, Adam M; Spivak, Emily S; Swaminathan, Sankar.
Afiliação
  • Gibson EG; Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • Pender M; Division of Infectious Diseases, Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • Angerbauer M; School of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • Cook C; Pulmonary and Critical Care, University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • Jones B; Pulmonary and Critical Care, University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • Spivak AM; Division of Infectious Diseases, Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • Spivak ES; Division of Infectious Diseases, Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • Swaminathan S; Department of Medicine, George E. Wahlen Veterans Affairs Medical Center, Salt Lake City, Utah, USA.
Open Forum Infect Dis ; 8(7): ofab176, 2021 Jul.
Article em En | MEDLINE | ID: mdl-34258310
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2021 Tipo de documento: Article